Clinical trial Recruiting at 1 site Observational Ages 18 to 80

MRI-derived Pressure Ratio (MPR) to predict stroke risk in intracranial atherosclerosis (ICAS)

Official title: MRI-Derived Pressure Ratio: a Novel Noninvasive Hemodynamic Biomarker for Stroke Risk Stratification in Intracranial Atherosclerotic Stenosis

Run by Xuanwu Hospital, Beijing · NCT07309718 · Data updated 2026-11-12

This study will test whether a new MRI-derived pressure ratio (MPR) can help predict 1-year stroke risk in adults (18–80) with 50–99% intracranial atherosclerotic stenosis in the anterior circulation.

More Stroke, Ischemic trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment400 (estimated)
SponsorXuanwu Hospital, Beijing
Academic / other
Locations1 site (Beijing, Xicheng District)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedDecember 15, 2027
Study endsMarch 31, 2028
Registry record updatedDecember 30, 2025
Trial IDNCT07309718 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–80 with symptomatic anterior-circulation intracranial atherosclerotic stenosis of 50–99% who can undergo MRI and give informed consent are the ideal candidates.

Probably not a fit

Patients with non-atherosclerotic intracranial disease, large baseline infarcts or baseline disability (mRS ≥3), contraindications to MRI, or significant ipsilateral extracranial carotid stenosis are unlikely to benefit from MPR measurement in this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a multicenter prospective single-arm registry enrolling 400 consecutive adults with symptomatic anterior-circulation ICAS and 50–99% stenosis. All participants receive standardized medical therapy per AHA/ASA guidelines and undergo multimodal imaging including TCD, CTA/MRA/DSA, high-resolution MRI, and phase-contrast MRA to calculate MPR. Participants are followed at baseline, 1 month, 6 months, and 12 months, with the primary outcome of ischemic stroke in the qualifying artery territory or related death within one year. An independent DSMB oversees safety and study conduct across five participating stroke centers coordinated by Xuanwu Hospital in Beijing.

Why it matters

Potential benefit: If successful, MPR could help doctors identify which patients with ICAS are at higher short-term stroke risk and guide more personalized prevention strategies.

How similar studies have gone: Pressure-based hemodynamic approaches are well established in coronary disease and have shown promise in limited neurovascular research, but MPR as an MRI-derived intracranial pressure ratio is a relatively novel application with limited prior large-scale validation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adults aged 18 to 80 years.
2. Intracranial atherosclerotic stenosis ICAS involving a culprit artery in the anterior circulation.
3. Intracranial arterial stenosis of 50% to 99% as measured by the WASID method using TCD, CTA, MRA, or DSA.
4. Written informed consent obtained from the participant or a legal representative.

Exclusion Criteria:

1. Non-atherosclerotic intracranial lesions, including moyamoya disease, vasculitis, vascular dissection, autoimmune diseases, or congenital/genetic abnormalities.
2. More than 50% stenosis of the extracranial carotid artery on the ipsilateral side.
3. Large cerebral infarction involving more than one-half of the territory on DWI imaging, or a baseline modified Rankin Scale score ≥3.
4. Contraindications to antiplatelet therapy or statins.
5. Inability to undergo MRI due to metal implants or claustrophobia.

Where it's running

  • Department of Neurosurgery, Xuanwu hospital
    Beijing, Xicheng District, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.